AnalysisMarch 14, 2026The Death of the MultivitaminTargeted Replenishment in the Post-Genomic Eraor decades, the “insurance policy” of a daily multivitamin has dominated the supplement industry. Massive-scale clinical reviews, however, paint an entirely different picture: antagonistic absorption, downregulated endogenous synthesis, and a critical importance of targeted dosing now define the conversation.Read Article
AnalysisMarch 10, 2026The Magnesium Threonate ParadoxBBB Penetration vs Systemic AbsorptionThe ongoing debate regarding elemental magnesium vs specific chelations misses a fundamental point. L-Threonate was designed specifically to elevate brain magnesium levels, crossing the blood-brain barrier with unprecedented efficiency. However, clinical focus has drifted.Read Article
AnalysisMarch 05, 2026Revisiting mTOR InhibitionIntermittent Dosing Strategies for LongevityRapamycin and its analogs have dominated the longevity discourse as the most potent pharmacological interventions for lifespan extension across multiple species. But chronic inhibition of mTORC1 introduces an unacceptable side-effect profile.Read Article